Pharmaceutical Industry in
Cham

AbbVie AG

Since 2012 · 101–500 empl.·4.0(3)

AbbVie AG researches, develops and markets biopharmaceutical medicines and solutions in areas such as immunology, oncology, neuroscience and eye care. The company also highlights patient-focused drug development, clinical trials and research partnerships.

AbbVie Biopharmaceuticals GmbH

Since 2012 · 51–100 empl.·4.0(3)

AbbVie Biopharmaceuticals GmbH researches and develops medicines and solutions for complex health conditions. The company focuses on several therapeutic areas, including immunology, oncology, neuroscience, eye care and medical aesthetics.

Medicor AG

Since 1993 · 1–10 empl.

Medicor AG provides solutions for a wide range of medical specialties, including cardiology, gastroenterology, pneumology, radiology, urology and veterinary medicine. Its services also include delivery, storage, repair and support.

GlobeMed Pharma Group AG

Since 1999 · 11–20 empl.

The core activity of Cannapharm AG is the production and distribution of cannabis extracts and other cannabis-based products for medical purposes. The company specializes in the manufacture of high-quality cannabis extracts, which are cultivated and produced in Switzerland, and offers these products to the specialist trade and pharmaceutical industry.

Catalent Pharma Solutions GmbH

Since 2000 · 101–500 empl.

Catalent Pharma Solutions GmbH is a global contract development and manufacturing organization (CDMO) providing development, manufacturing and supply services to pharmaceutical, biotech and consumer health companies. Services include oral dose and softgel technologies, biologics and specialty manufacturing, clinical supply and formulation and delivery technology support.

Devatis AG

Since 2014 · 11–20 empl.

The core activity of Devatis AG is the manufacture and distribution of high-quality pharmaceutical finished products and active ingredients, particularly generics, in various therapeutic areas such as hematology, oncology, ophthalmology and respiratory system.

Partex.AI Therapeutics AG

Since 2021 · 11–20 empl.

The core activity of Cureteq consists of two main areas: 1. **Asset Management**: The company offers services in the field of asset management, which indicates that it is involved in the management and optimization of assets, such as financial investments or company participations. 2. **Biotechnology**: Cureteq is also active in biotechnology, which indicates that it is involved in the development and application of biotechnological processes and products, such as the development of medicines or the application of genetic engineering. Both areas are supported by the application of **artificial intelligence (AI)**, which indicates that the company uses AI technologies to optimize and improve its activities.

Oncoteq AG

Since 2022 · 11–20 empl.

The core activity of Oncoteq AG is the development of oncological treatments using artificial intelligence (AI) in the clinical stage.

Maras AG

Since 1989 · 1–10 empl.·5.0(1)

The core activity of MARAS AG is to provide services in the areas of Regulatory Affairs, Quality Assurance and Pharmacovigilance for the Swiss and international pharmaceutical industry. Specifically, this includes support in the approval of medicinal products, quality assurance, drug safety, compliance, reimbursement and consulting and training of employees in the pharmaceutical industry.

Daliom Biopharmaceuticals AG

Since 2018 · 1–10 empl.

The core activity of Daliom Biopharmaceuticals is the development and manufacturing of biopharmaceutical products, including diagnostic tools, therapeutic proteins and personalized medicines tailored to the individual genetic profile of patients. The company focuses on the treatment of diseases such as cancer, autoimmune diseases, neurodegenerative diseases and other life-threatening or chronic conditions.

DMW AG

Since 1979 · 1–10 empl.

Rienheim GmbH

Since 2000 · 1–10 empl.